![Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022 Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022](https://journals.sagepub.com/cms/10.1177/20451253221105128/asset/images/large/10.1177_20451253221105128-fig3.jpeg)
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022
![Mechanism of action of Agomelatine [21,27]. Therefore, in the present... | Download Scientific Diagram Mechanism of action of Agomelatine [21,27]. Therefore, in the present... | Download Scientific Diagram](https://www.researchgate.net/publication/257890065/figure/fig1/AS:202869371346952@1425379235884/Mechanism-of-action-of-Agomelatine-21-27-Therefore-in-the-present-paper-we-report.png)
Mechanism of action of Agomelatine [21,27]. Therefore, in the present... | Download Scientific Diagram
![Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022 Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022](https://journals.sagepub.com/cms/10.1177/20451253221105128/asset/images/large/10.1177_20451253221105128-img1.jpeg)
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022
![Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action | The Journal of Neuropsychiatry and Clinical Neurosciences Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action | The Journal of Neuropsychiatry and Clinical Neurosciences](https://neuro.psychiatryonline.org/cms/10.1176/appi.neuropsych.11090216/asset/images/medium/290f2.gif)
Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action | The Journal of Neuropsychiatry and Clinical Neurosciences
![Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats - ScienceDirect Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221005898-ga1.jpg)
Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats - ScienceDirect
![Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022 Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022](https://journals.sagepub.com/cms/10.1177/20451253221105128/asset/images/large/10.1177_20451253221105128-fig1.jpeg)
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action - Mark J. Millan, 2022
![Agomelatine, the first melatonergic antidepressant: discovery, characterization and development | Nature Reviews Drug Discovery Agomelatine, the first melatonergic antidepressant: discovery, characterization and development | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd3140/MediaObjects/41573_2010_Article_BFnrd3140_Fig4_HTML.jpg)
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development | Nature Reviews Drug Discovery
![Frontiers | Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice Frontiers | Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice](https://www.frontiersin.org/files/Articles/766410/fnagi-13-766410-HTML/image_m/fnagi-13-766410-g001.jpg)